Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in LLY — ELI LILLY & Co

CIK 1000275 TORONTO, A6
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,227,597,337
+$1,307,049,207 QoQ
Shares Held
4,358,401
+2.2% QoQ
Ownership
0.463%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#33
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 1% None 1%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$89,957,257
CallShares
75,000
PutValue
$959,544
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. LLY ranks #1 (27.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		4,358,401 $5,227,597,337
2 JNJ
Johnson & Johnson
 13,211,475 $3,355,318,297
3 ABBV
AbbVie Inc.
 8,163,806 $2,054,340,133
4 AZN
Astrazeneca PLC
 10,427,503 $1,977,263,112
5 MRK
Merck & Co., Inc.
 14,293,086 $1,836,661,547
6 AMGN
Amgen Inc
 4,328,785 $1,567,539,618
7 PFE
Pfizer Inc
 32,814,260 $790,167,373
8 BMY
Bristol Myers Squibb Co
 12,094,886 $696,907,326

All Filings in LLY

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,227,597,337 4,358,401
2026-06-30 $959,544 800
2026-06-30 $89,957,257 75,000
2026-03-31 $735,816 800
2026-03-31 $3,920,548,130 4,262,531
2025-12-31 $161,631,887 150,400
2025-12-31 $145,081,813 135,000
2025-12-31 $4,696,065,087 4,369,733
2025-09-30 $3,094,212,212 4,055,324
2025-09-30 $152,600 200
2025-09-30 $76,300,000 100,000
2025-06-30 $155,906 200
2025-06-30 $2,988,093,609 3,833,199
2025-06-30 $77,953,000 100,000
2025-03-31 $49,554,600 60,000
2025-03-31 $3,141,469,262 3,803,646
2024-12-31 $11,580,000 15,000
2024-12-31 $2,100,903,816 2,721,378
2024-09-30 $2,263,049,559 2,554,405
2024-09-30 $44,297,000 50,000
2024-06-30 $2,182,110,653 2,410,160
2024-03-31 $1,814,643,818 2,332,567
2023-12-31 $1,370,717,718 2,351,468
2023-09-30 $1,191,914,561 2,219,043
2023-06-30 $1,108,365,282 2,363,353
2023-03-31 $785,986,722 2,288,704
2022-12-31 $906,901,256 2,478,956
2022-09-30 $12,254,965 37,900
2022-09-30 $762,298,913 2,357,504
2022-06-30 $748,835,443 2,309,581
2022-06-30 $8,462,403 26,100
2022-03-31 $654,287,574 2,284,763
2022-03-31 $11,311,615 39,500
2021-12-31 $671,562,631 2,431,260
2021-09-30 $3,558,170 15,400
2021-09-30 $557,790,275 2,414,154
2021-06-30 $563,359,589 2,454,512
2021-03-31 $470,189,878 2,516,807
2020-12-31 $465,539,320 2,757,281
2020-09-30 $412,311,183 2,785,510
2020-06-30 $400,319,429 2,438,296
2020-03-31 $280,517,081 2,022,182
2020-03-31 $39,535,200 285,000

Report a Problem

Category
Description
Email (optional, for follow-up)